New Rapid-acting Antidepressants, 1st ed. 2021 Contemporary Clinical Neuroscience Series
First Name – Kenji
Last Name – Hashimoto
Institution - Chiba University Center for Forensic Mental Health
Department - Division of Clinical Neuroscience
City – Chiba 260-8670
State – Chiba
Country – Japan
Email – hashimoto@faculty.chiba-u.jp
Kenji Hashimoto, PhD
Chiba University, Chiba, JapanDr. Hashimoto is a professor and vice-director of Chiba University Center for Forensic Mental Health from 2005. Dr. Hashimoto graduated from Faculty of Pharmaceutical Sciences at Kyushu University, and received PhD. After Dr. Hashimoto worked at Fukuyama University, National Institutes of Health (NIH)/National Institute of Drug Addiction (NIDA)(Baltimore, MD, USA) and Pharmaceutical company, he moved at Chiba University Graduate School of Medicine from 2001. Dr. Hashimoto works on the development of novel therapeutic drugs for psychiatric and neurological disorders. Dr. Hashimoto published more than 550 articles in PubMed listed publications. Dr. Hashimoto focus on the molecular and cellular mechanisms of ketamine’s antidepressant actions.
Discusses new candidate for rapid-acting antidepressants
Provides information for those who work in the field of CNS drugs
Ideal for pharmacologists, psychiatrists, and those who want to learn about CNS drugs at the graduate level
Date de parution : 10-2022
Ouvrage de 149 p.
15.5x23.5 cm
Date de parution : 10-2021
Ouvrage de 149 p.
15.5x23.5 cm